BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Jeff Collins will participate on a panel titled "Funding Innovation, Cross-Border Investments and M&A Trends" at the US India BioPharma & Healthcare Summit in Cambridge, MA
News | 05. 14. 2009
